Assessing the Impact of the Personalized Medicine Clinic on Mental Health Outcomes

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

The aim of this study is to investigate if personalized dosing of antidepressant medications using information gathered at the Personalized Medicine Clinic can improve patients' mental health. The main question it aims to answer is if the Personalized Medicine Clinic can improve depressive symptoms based on the CES-D survey score.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Depressive symptoms

Disqualifiers

Patients who do not speak English

Patients with severe mental illness including hospitalized patients or patients with suicidal ideation

Trial population

Adult patients referred to the Personalized Medicine clinic for genotype-guided drug dosing and selection related to mental health pharmacotherapy as part of clinical care.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Personalized Medicine Clinic

    Other intervention

    Personalized Medicine Clinic services with specific focus on pharmacogenetic recommendations and patient education.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Personalized Medicine Cohort1 intervention

Trial outcomes

Primary outcomes

1

CES-D Survey Score

CES-D survey score is a 20-item self-reported questionnaire that was designed to assess depressive symptoms. The score is from 0-60 with higher numbers indicating greater depressive symptoms.

Time frame
From enrollment to 6 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: